Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

A Comprehensive, Evidence-Based Review of GLP-1/GIP Agonists for Fitness and Wellness Professionals ...

Interestingly, glipizide was very similar to repaglinide with respect to the effects on the early phase. Moreover, glipizide reached significance against glibenclamide in both groups of subjects ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

They show a weight loss effect of about 15 to 20% ... agent that activates not only GLP-1 but also glucose-dependent insulinotropic polypeptide (GIP) and glucagon (GCG) simultaneously.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...